Pierre Wallemacq

Pierre Wallemacq

Université Catholique de Louvain - Louvain-la-Neuve / Belgium
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 1401178
Catholic University of Louvain
person_outline Pierre Wallemacq's MOST POPULAR ARTICLES
1-) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus reportM Brunet, T Van Gelder, A Åsberg, V Haufroid, DA Hesselink, L Langman, ...Therapeutic drug monitoring 41 (3), 261-307, 20195722019
2-) The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patientsV Haufroid, M Mourad, V Van Kerckhove, J Wawrzyniak, M De Meyer, ...Pharmacogenetics and Genomics 14 (3), 147-154, 20045722004
3-) Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conferenceP Wallemacq, VW Armstrong, M Brunet, V Haufroid, DW Holt, A Johnston, ...Therapeutic drug monitoring 31 (2), 139-152, 20095512009
4-) Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shockFS Taccone, PF Laterre, T Dugernier, H Spapen, I Delattre, X Wittebole, ...Critical care 14, 1-9, 20104652010
5-) Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.M Buysschaert, AS Dramais, PE Wallemacq, MP HermansDiabetes care 23 (12), 1816-1822, 20003762000